about
miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in micePhysical and functional interaction of androgen receptor with calmodulin in prostate cancer cellsProgesterone receptors--animal models and cell signalling in breast cancer. Diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancerThe Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem CellsEnvironmental causes of cancer: endocrine disruptors as carcinogensIn situ vaccination combined with androgen ablation and regulatory T-cell depletion reduces castration-resistant tumor burden in prostate-specific pten knockout mice.The etiology of colon cancer.Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies.Current state of practice regarding testosterone supplementation therapy in men with prostate cancerMechanism of androgen receptor antagonism by bicalutamide in the treatment of prostate cancerAbrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.The effectiveness of combining hormone therapy and radiotherapy in the treatment of prostate cancer.17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer.The challenge of osteosarcoma.Carcinogenesis explained within the context of a theory of organisms.GPX2 overexpression is involved in cell proliferation and prognosis of castration-resistant prostate cancer.Disodium pentaborate decahydrate (DPD) induced apoptosis by decreasing hTERT enzyme activity and disrupting F-actin organization of prostate cancer cells.Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancerAllosteric conversation in the androgen receptor ligand-binding domain surfaces.Androgen stimulated cellular proliferation in the human prostate cancer cell line LNCaP is associated with reduced retinoblastoma protein expression.The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory[Effect of hypothyroidism on the solid form of Ehrlich tumor in intact or castrated adult female mice].Impact of hormone therapy on acute radiotherapy toxicity in the treatment of prostate cancer.Marshall R. Urist and the discovery of bone morphogenetic proteins.The Addition of Manganese Porphyrins during Radiation Inhibits Prostate Cancer Growth and Simultaneously Protects Normal Prostate Tissue from Radiation Damage.Somatic mutation theory of carcinogenesis: why it should be dropped and replaced.miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.
P2860
Q21142723-F7672293-2EA9-439C-A01B-5A3F5B61C762Q24598075-A9048F4B-3CBD-423A-98BD-A52BAE4E0882Q24800251-E3AA76AF-5CF8-4B6C-8429-8540A2B23EA2Q26765892-571AEA92-F122-45B9-A573-DDE99C60B021Q28283271-32098039-B780-4400-BA10-A6200C64B551Q33837085-BFE6AE99-7D05-4C1E-A3ED-5FAF409591F1Q34066762-4747034C-D31E-4515-97D1-7E7C5735E0A2Q34267991-DD943148-FD85-4590-8B41-8969E328B66BQ34293663-3192A4E8-BB6D-4630-93F1-FFA5EAFD5566Q34996358-06D8DF42-DA1D-451C-9239-BDC5FD28DF8DQ35861043-1134584E-085C-4230-A912-3763CCB7B275Q35967325-407304E1-C3D6-4A7C-8796-C33AF1BC27FDQ37363103-DACDD8B8-ECC1-4026-8B0D-0339F92F55A3Q37484581-9AE8AFFD-0206-4775-A535-4821D222B0A3Q38539298-B6B85ADD-81F4-4F15-B12B-F69449DF20AAQ38920835-C99E0F7A-7144-438B-A8A7-5DF3180FA7FBQ39021568-E789CDB1-93D8-4106-B8F1-8736179C8D47Q39079692-3F357C4C-0DA2-4B9C-8E85-8922BD34F7D0Q39128975-F457D274-CF94-49DE-813A-7ABBDE724FADQ39338812-74BC35CF-E39D-442E-9856-19D93E7CAE19Q40762889-69603767-BF72-487B-96C6-CD9CF3D7C180Q41789765-EF661CEB-9DCD-408D-88D0-D13F1B0442CCQ46371354-7EA96055-42BB-4175-B193-0A22A9029744Q46570962-95A6BE01-B9F2-43A6-9664-D48353C7410AQ47439937-6240AAAF-3214-4F2B-804E-C7ED66FFAFC1Q49184042-F1A13444-00F1-446A-82E6-70EAD84904BFQ52542105-526BD0AD-92AC-4B88-BD90-C7002D2FE0AFQ53278601-03C2745D-0F73-41A3-9ACD-4DC272DC5E23
P2860
description
1967 nî lūn-bûn
@nan
1967年の論文
@ja
1967年論文
@yue
1967年論文
@zh-hant
1967年論文
@zh-hk
1967年論文
@zh-mo
1967年論文
@zh-tw
1967年论文
@wuu
1967年论文
@zh
1967年论文
@zh-cn
name
Endocrine-induced regression of cancers.
@en
type
label
Endocrine-induced regression of cancers.
@en
prefLabel
Endocrine-induced regression of cancers.
@en
P1433
P1476
Endocrine-induced regression of cancers.
@en
P2093
P304
P356
10.1126/SCIENCE.156.3778.1050
P407
P577
1967-05-01T00:00:00Z